Discovery and Design of Peptides as MMP9 Inhibitors through Structure-Based Molecular Docking for Targeted Mantle Cell Lymphoma Therapy

Yan, W; Yang, Y; Yang, W; Wei, MJ

Yang, W (corresponding author), China Med Univ, Dept Hematol, Shengjing Hosp, Shenyang, Liaoning, Peoples R China.; Wei, MJ (corresponding author), China Med Univ, Sch Pharm, Dept Pharmacol, Shenyang, Liaoning, Peoples R China.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021; 21 (12): 1551

Abstract

Background: Enhanced expression and activation of metalloproteinase-9 (MMP9) are associated with mantle cell lymphoma (MCL) progression, invasion and ......

Full Text Link